<p><strong>Atricure</strong>（納斯達克股票代碼：ATRC）將於 2026 年 2 月 17 日（星期二）發佈最新的季度財報。以下是投資者在公告前需要了解的信息。</p>
<p>分析師預計 Atricure 將報告每股收益（EPS）為$-0.04。</p>
<p>Atricure 的公告備受期待，投資者希望獲得超出預期的消息以及對下個季度的積極指引。</p>
<p>值得新投資者注意的是，指引可能是股價波動的關鍵因素。</p>
<h3>歷史收益表現</h3>
<p>在上個季度，該公司報告的每股收益超出預期$0.10，導致次日股價下跌 3.81%。</p>
<p>以下是 Atricure 的過去表現及其導致的價格變化：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 預估</strong></td>
<td align="right">-0.11</td>
<td align="right">-0.16</td>
<td align="right">-0.22</td>
<td align="right">-0.15</td>
</tr>
<tr>
<td><strong>EPS 實際</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td align="right">-0.14</td>
<td align="right">-0.08</td>
</tr>
<tr>
<td><strong>價格變化 %</strong></td>
<td align="right">-4.00</td>
<td align="right">11.00</td>
<td align="right">-14.00</td>
<td align="right">-7.00</td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png"/></p>
<h3>Atricure 股價分析</h3>
<p>截至 2 月 12 日，Atricure 的股票交易價格為$31.8。在過去的 52 周內，股價下跌了 14.57%。鑑於這些回報通常為負，長期股東在此次財報發佈前可能感到不滿。</p>
<h3>分析師對 Atricure 的看法</h3>
<p>瞭解市場情緒和行業內的預期對投資者至關重要。本文分析了 Atricure 的最新見解。</p>
<p>根據分析師評級，Atricure 的共識評級為。平均一年價格目標為$，表明潛在的。</p>
<p>要跟蹤 Atricure 的所有財報發佈，請訪問我們網站上的財報日曆。</p>
<p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>

ATRC

<p>AtriCure（納斯達克代碼：ATRC）將於 2026 年 2 月 17 日公佈季度財報，分析師預計每股收益（EPS）為-0.04 美元。投資者熱切期待此次公告，以期獲得潛在的積極指引。上個季度，AtriCure 的每股收益超出預期 0.10 美元，但股價隨後下跌了 3.81%。目前，股價為 31.8 美元，過去一年下跌了 14.57%。分析師評級和市場情緒對投資者在財報發佈前至關重要</p>

<p><strong>AtriCure</strong> (NASDAQ: ATRC) is set to give its latest quarterly earnings report on Tuesday, 2026-02-17. Here's what investors need to know before the announcement.</p>
<div class="lb-trans"><p><strong>Atricure</strong>（納斯達克股票代碼：ATRC）將於 2026 年 2 月 17 日（星期二）發佈最新的季度財報。以下是投資者在公告前需要了解的信息。</p>
</div><p>Analysts estimate that AtriCure will report an <strong>earnings per share</strong> (EPS) of $-0.04.</p>
<div class="lb-trans"><p>分析師預計 Atricure 將報告每股收益（EPS）為$-0.04。</p>
</div><p>The announcement from AtriCure is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<div class="lb-trans"><p>Atricure 的公告備受期待，投資者希望獲得超出預期的消息以及對下個季度的積極指引。</p>
</div><p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<div class="lb-trans"><p>值得新投資者注意的是，指引可能是股價波動的關鍵因素。</p>
</div><h3>Historical Earnings Performance</h3>
<div class="lb-trans"><h3>歷史收益表現</h3>
</div><p>During the last quarter, the company reported an EPS beat by $0.10, leading to a 3.81% drop in the share price on the subsequent day.</p>
<div class="lb-trans"><p>在上個季度，該公司報告的每股收益超出預期$0.10，導致次日股價下跌 3.81%。</p>
</div><p>Here's a look at AtriCure's past performance and the resulting price change:</p>
<div class="lb-trans"><p>以下是 Atricure 的過去表現及其導致的價格變化：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">-0.11</td>
<td align="right">-0.16</td>
<td align="right">-0.22</td>
<td align="right">-0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td align="right">-0.14</td>
<td align="right">-0.08</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-4.00</td>
<td align="right">11.00</td>
<td align="right">-14.00</td>
<td align="right">-7.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 預估</strong></td>
<td align="right">-0.11</td>
<td align="right">-0.16</td>
<td align="right">-0.22</td>
<td align="right">-0.15</td>
</tr>
<tr>
<td><strong>EPS 實際</strong></td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td align="right">-0.14</td>
<td align="right">-0.08</td>
</tr>
<tr>
<td><strong>價格變化 %</strong></td>
<td align="right">-4.00</td>
<td align="right">11.00</td>
<td align="right">-14.00</td>
<td align="right">-7.00</td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1771272088_0.png" alt="eps graph" original-src="https://www.benzinga.com/files/images/story/2026/1771272088_0.png"/></p>
<h3>AtriCure Share Price Analysis</h3>
<div class="lb-trans"><h3>Atricure 股價分析</h3>
</div><p>Shares of AtriCure were trading at $31.8 as of February 12. Over the last 52-week period, shares are down 14.57%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.</p>
<div class="lb-trans"><p>截至 2 月 12 日，Atricure 的股票交易價格為$31.8。在過去的 52 周內，股價下跌了 14.57%。鑑於這些回報通常為負，長期股東在此次財報發佈前可能感到不滿。</p>
</div><h3>Analyst Opinions on AtriCure</h3>
<div class="lb-trans"><h3>分析師對 Atricure 的看法</h3>
</div><p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on AtriCure.</p>
<div class="lb-trans"><p>瞭解市場情緒和行業內的預期對投資者至關重要。本文分析了 Atricure 的最新見解。</p>
</div><p>With analyst ratings, AtriCure has a consensus rating of . The average one-year price target is $, indicating a potential .</p>
<div class="lb-trans"><p>根據分析師評級，Atricure 的共識評級為。平均一年價格目標為$，表明潛在的。</p>
</div><p>To track all earnings releases for AtriCure visit their earnings calendar on our site.</p>
<div class="lb-trans"><p>要跟蹤 Atricure 的所有財報發佈，請訪問我們網站上的財報日曆。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</em></p>
</div>

Atricure 即將發佈的財報洞察